fashion -WSS

fashion

author：explore 2025-09-28 18:47:51 - browse：9848

European Medicines Agency Suffers Cyber Attack in Amsterdam — Paulo Amorim / VWPics via AP Images

LONDON — Two days after similar decisions in the U.S. and U.K., regulators in Europe on Friday recommended that the approval of Eli Lilly’s diabetes drug Mounjaro be widened to include obesity.

The ruling from a committee of the European Medicines Agency now goes to the European Commission, which makes the final decision but almost always follows the EMA’s guidance.

Mounjaro, known scientifically as tirzepatide, is one of an emerging class of drugs that target receptors of the GLP-1 hormone, and sometimes other molecules, and that have had dramatic effects on weight loss. Doctors have been prescribing the diabetes drugs off-label for obesity, but having specific authorization could streamline the process of getting the medicines.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： ‘Oppenheimer’ and the risks of AI in health care

WSS

Pharma showers House GOP doctor with campaign cash

2 officers injured in shooting in Orlando, police say

What the US credit downgrade means for the economy, your finances

Chris Christie meets with Zelenskyy during Ukraine trip

Alnylam reports growth in sales of rare disease treatments

Physicians aren't 'burning out.' They're suffering from moral injury

entertainment

fashion

focus

Medical records are filled with copy

Late stage cancers on the rise after pandemic delayed screenings

The cancer drug shortage isn’t new — and neither are the solutions

Heart disease in astronauts blamed on cosmic radiation

In age of alternative facts, a scholarly course on calling out crap

How I helped Pfizer think through the ethics of Viagra

Drug repurposing or repositioning? The language matters

Listen: Biotech layoffs, eye drug drama, & gene therapy milestones

DIEP, the 'gold standard' of breast reconstruction, is under threat

What the airline industry can learn from medicine

leisure time

Scientists inch closer to single

How to ethically and practically extend health care to all

Alnylam reports growth in sales of rare disease treatments

Amazon expands telehealth clinic nationwide

‘Oppenheimer’ and the risks of AI in health care

The a glaring gap in research on serious mental illness and primary care

explore

focus

hotspot

focus